Peptide Synthesizers Market: Overview
Peptides are those chains of amino acids that comprise the building blocks of all the main living organisms. In-vitro production of peptides can be obtained by making use of individual amino acids and then binding them according to their desired sequence in a very controlled environment. Previously, synthetic peptides were made by making use of the liquid phase method and that was majorly substituted by the method of solid phase. Before peptide synthesizer systems were introduced, in-vitro synthesis of peptides has been a time-consuming process and it comprised high consumption of resources, highly skilled operators, and complexity. Peptide synthesizers make an offering of the ability to synthesize and build complex peptides in a short period of time from the level of research to the level of production. In addition to that, advanced peptide synthesizers are able to synthesize multiple peptides at the same time. Synthetic peptides are utilized so as to produce certain antibody epitopes and enzyme-binding sites and for the purpose of development and designing of enzymes, vaccines, and drugs.
Considering the international vendor landscape, the world market for peptide synthesizers can be considered as moderately fragmented and the market players focus on strategically important partnerships, collaborations, mergers, and acquisitions.
Peptide Synthesizers Market: Trends and Opportunities
The international market for peptide synthesizers is driven by certain factors. Constantly changing landscape of the industry of healthcare with more emphasis on the development of novel therapeutics for the disorders and diseases are expected to bring in more investments in the programmes of research and development in various industrial and public segments. This is expected to fuel the world market for peptide synthesizers over the period of forecast that extends from 2017 to 2025. In addition to that, rising inclination in the industry of pharmaceuticals towards peptide therapeutics and biosimilars is forecasted to encourage the said market. Rising viral and parasitic infections across the world and rising prevalence of various chronic diseases are very likely to bolster the demand for latest diagnostic tools by making use of specific antibodies. This is further expected to give in vitro peptide synthesis a rise thereby fuelling world market for peptide synthesizers in the forthcoming years. Apart from pharmaceutical and health care sectors, adoption and consumption of synthetic peptides are rising in various industries like environment, biosensors, and food & beverages. Synthetic peptides are utilized for the purpose of research and development activities and production purposes in the above-mentioned industries. This factor is expected to propel the global market for peptide synthesizers over the period of forecast.
The international market for peptide synthesizers has been segregated on the basis of end-user, system capacity, technology, product, and region.
Peptide Synthesizers Market: Geography
In terms of geography, the world market for peptide synthesizers has been segmented into North America, Asia Pacific, Europe, and Rest of World. Rapid and wide adoption of technology and increased expenditure both by the private and public sectors on the activities of research and development are elements that are likely to contribute towards high share that is being held by the region of North America in the world market. The region of Europe is expected to hold substantial share of the world market over the period of forecast owing to well-established biotechnology and pharmaceutical industry in the said region. Expanding base of academic research institutes and contract research organizations in many of the emerging markets like India and China is likely to encourage the market in Asia Pacific throughout the period of forecast.
Peptide Synthesizers Market: Company Profiling
Major market participants that are operating in the world market for peptide synthesizers include names like Advanced ChemTech Inc., GYROS PROTEIN TECHNOLOGIES AB, AAPPTec, LLC, Activotec, HB Technologies AG (Intavis), CSBio Company Inc., Shimadzu Corporation, Biotage, PerSpective Biosystems, Inc., Thermo Fisher Scientific, and CEM Corporation.
For the purpose of this study, the market has been segmented as follows:
- Global Peptide Synthesizers Market, by Product
- Single Channel
- Global Peptide Synthesizers Market, by Technology
- Global Peptide Synthesizers Market, by System Capacity
- Global Peptide Synthesizers Market, by End-User
- Academic Research Institutes
- Pharmaceutical & Biotechnology Industry
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.